Background Ulcerative colitis is a chronic inflammatory bowel disease with an estimated 150
000 patients in Germany alone. Methods This review is based on publications about current …

Ulcerative colitis is a relapsing and remitting disease that is increasing in incidence and
prevalence. Management aims to achieve rapid resolution of symptoms, mucosal healing …

Historically, medical therapy for ulcerative colitis (UC) was limited to corticosteroids.
Excitingly, over the past just 1–2 decades, the options for medical therapy have expanded …

Background & Aims The medical management of ulcerative colitis (UC) has improved
through the development of new therapies and novel approaches that optimize existing …

When deciding the appropriate treatment strategy for active ulcerative colitis one should
consider the activity, distribution (proctitis, left-sided, extensive 1), and pattern of disease …

Background There are limited data to inform positioning of agents for treating moderate‐
severe ulcerative colitis (UC). Aim To assess comparative efficacy and safety of different …

Ulcerative colitis (UC) is a chronic idiopathic inflammatory disorder that involves any part of
the colon starting in the rectum in a continuous fashion presenting typically with symptoms …

Conventional medical treatment for ulcerative colitis can have limited efficacy or severe
adverse reactions requiring additional treatment or colectomy. Hence, different biological …

The clinical course of ulcerative colitis (UC) may range from a quiescent course with
prolonged periods of remission to fulminant disease requiring intensive medical treatment or …

Ulcerative colitis (UC) is a chronic disease featuring recurrent inflammation of the colonic
mucosa. The goal of medical treatment is to rapidly induce a steroid-free remission while at …